BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

RICHIES SPECIALTY PHARMACY — Lobbying — Receipts Report

LD-2 disclosure · 4th Quarter - Report

RICHIES SPECIALTY PHARMACY

via ATLANTIC STRATEGIES GROUP LLC

4th Quarter (Oct 1 - Dec 31) · 2015Posted Jan 8, 2016Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: RICHIES SPECIALTY PHARMACY
Description: pharmaceutical compounding company
Location: Texas · United States of America

Registrant

Firm: ATLANTIC STRATEGIES GROUP LLC
Description: Government relations firm
Location: Washington D.C., District of Columbia, United States of America

Lobbying activities

1 issue

Defense
Worked with Congress to address specific compounding pharmacy policies within DOD's TRICARE program.
LobbyistsHELEN C SIRACUSE
TargetedSENATE

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.